Ran Agam

Vascular Graft Solutions Ltd. develops a special device to reduce graft failure rate in order to prevent re-do CABG (Coronaly artery bypass grafting) operation and other secondary interventions in coronary patients. The firm has developed the VEST, a novel Venous External STent for vein grafts. The device is kink-resistant external stent which is deployed over the entire vein graft without interfering with or changing the normal course of the CABG procedure. The company was founded by Eyal Orion in 2009 and is headquartered in Tel Aviv, Israel.

Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Champel Capital Ltd. (Champel Capital) is a venture capital firm founded in 2017 by Arie Benguigui and Amir Weitmann. The firm is headquartered in Israel.

Perflow Medical Ltd. manufactures endovascular devices. It develops Stream for the treatment of neurovascular disorders including brain aneurysms. The company was founded by Gilad Cibulski in 2010 and is headquartered in Tel Aviv, Israel.

Body Vision Medical Ltd. operates as a revolutionary platform for lung cancer diagnostics and treatment. The firm’s products include lungvision system and lungvision tool. The company was founded by Dorian Averbuch in 2014 is headquartered in Ramat Ha Sharon, Israel.

HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France.

Sahajanand Medical Technologies Ltd. operates as a global developer and manufacturer of minimally invasive cardiovascular devices. It offers coronary, structural heart and closure devices products. The company was founded by Dhirajlal Kotadia in 1992 and is headquartered in Surat, India.

Valiance Life Science Investments (Valiance Life Science Investments) is a private equity subsidiary of Valiance Asset Management Ltd. founded in 2017. The firm headquartered in London, United Kingdom.

Lungpacer Medical, Inc. engages in the development of therapeutic solutions for critically ill patients who require mechanical ventilation. It offers Lungpacer Diaphragm Pacing Therapy, a system designed for preserving or restoring strength of the diaphragm muscle. The company was founded by Andy Hoffer in 2009 and is headquartered in Vancouver, Canada.

Valiance Asset Management Ltd. provides investment services. It offers sovereign funds, pension funds, leading families and individuals investment services. The company was founded by Jan Pensaert in 2008 and is headquartered in St. Peter Port, Guernsey.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium.